• Executive Series 9 Mar 20: Immutep Ltd (IMM) CEO, Marc Voigt

    Immutep Ltd (IMM) CEO, Marc Voigt speaks with Tom Piotrowski about the company’s clinical trials focusing on immunotherapy drugs for cancer & autoimmune diseases, main product candidate & development strategies to support the product pipeline.
    Watch
  • 3697 < Discover more events
    Interested in the ASX listed companies in this event? Check out the latest news, announcements, financial data, and capital raise history for: